Literature DB >> 17680839

Vitrectomy without internal limiting membrane peeling for macular retinoschisis and foveal detachment in highly myopic eyes.

Shu-I Yeh1, Wei-Chun Chang, Lee-Jen Chen.   

Abstract

PURPOSE: To report the surgical outcome of pars plana vitrectomy (PPV) without internal limiting membrane (ILM) peeling in three highly myopic patients with macular retinoschisis and associated posterior staphyloma.
METHODS: We report three highly myopic patients with macular retinoschisis and foveal detachment who underwent simple PPV without ILM peeling, with long-acting gas tamponade. Main outcome evaluations included best corrected visual acuity, biomicroscopic appearance and optical coherence tomography findings.
RESULTS: Pars plana vitrectomy without ILM peeling resulted in anatomic and functional improvement in all three operated eyes for follow-up periods of > or = 12 months.
CONCLUSIONS: Pars plana vitrectomy without ILM peeling is effective for treating macular retinoschisis and foveal detachment in highly myopic eyes with posterior staphyloma. Visual and anatomic outcomes are comparable with those in previous studies in which ILM removal was performed.

Entities:  

Mesh:

Year:  2007        PMID: 17680839     DOI: 10.1111/j.1600-0420.2007.00974.x

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  10 in total

1.  Treatment of myopic foveoschisis via macular buckling and vitrectomy.

Authors:  Si-Qi Xiong; Hai-Bo Jiang; Fang-Ling Li; Yan-Xiu Li; Jie Yang; Xiao-Bo Xia; Hui-Zhuo Xu
Journal:  Int J Ophthalmol       Date:  2017-05-18       Impact factor: 1.779

2.  Morphologic and functional outcomes of different optical coherence tomography patterns of myopic foveoschisis after vitrectomy and inner limiting membrane peeling.

Authors:  Giancarlo Sborgia; Francesco Boscia; Alfredo Niro; Ermete Giancipoli; Giuseppe D'Amico Ricci; Alessandra Sborgia; Luigi Sborgia; Nicola Recchimurzo; Mario R Romano; Giuseppe Addabbo; Giovanni Alessio
Journal:  Eye (Lond)       Date:  2019-06-17       Impact factor: 3.775

3.  Long-term follow-up of vitrectomy in patients with pathologic myopic foveoschisis.

Authors:  Ting Zhang; Ying Zhu; Chun-Hui Jiang; Ge-Zhi Xu
Journal:  Int J Ophthalmol       Date:  2017-02-18       Impact factor: 1.779

4.  Fovea sparing versus complete internal limiting membrane peeling for myopic traction maculopathy: a meta-analysis.

Authors:  Guohai Chen; Sihong Mao; Yuhua Tong; Fangzheng Jiang; Jiasong Yang; Wensheng Li
Journal:  Int Ophthalmol       Date:  2021-10-08       Impact factor: 2.031

5.  Combined 23-gauge transconjunctival sutureless vitrectomy and cataract surgery in cases with cataract and posterior segment diseases.

Authors:  Ahmet Taylan Yazici; Necip Kara; Ercument Bozkurt; Mehmet Cakir; Hasan Goker; Ahmet Demirok; Omer Faruk Yilmaz
Journal:  Middle East Afr J Ophthalmol       Date:  2010-10

6.  Suprachoroidal buckling: technique and indications.

Authors:  Ehab N El Rayes; Ebrahim Elborgy
Journal:  J Ophthalmic Vis Res       Date:  2013-10

Review 7.  Vitreous tamponades in highly myopic eyes.

Authors:  X Valldeperas; J Lorenzo-Carrero
Journal:  Biomed Res Int       Date:  2014-06-02       Impact factor: 3.411

8.  Comparison of effectiveness between complete internal limiting membrane peeling and internal limiting membrane peeling with preservation of the central fovea in combination with 25G vitrectomy for the treatment of high myopic foveoschisis.

Authors:  Lifei Wang; Yanhui Wang; Yalin Li; Zhongyang Yan; Yunhuan Li; Lu Lu; Tianxiang Lu; Xin Wang; Shengjuan Zhang; Yanxia Shang
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

9.  Favorable anatomic and visual outcomes with 25-gauge vitrectomy for myopic foveoschisis.

Authors:  Mei Mii; Masato Matsuoka; Kayako Matsuyama; Yayoi Otsu; Tetsuya Nishimura
Journal:  Clin Ophthalmol       Date:  2014-09-12

Review 10.  Internal limiting membrane peeling and gas tamponade for myopic foveoschisis: a systematic review and meta-analysis.

Authors:  Bo Meng; Lu Zhao; Yi Yin; Hongyang Li; Xiaolei Wang; Xiufen Yang; Ran You; Jialin Wang; Youjing Zhang; Hui Wang; Ran Du; Ningli Wang; Siyan Zhan; Yanling Wang
Journal:  BMC Ophthalmol       Date:  2017-09-08       Impact factor: 2.209

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.